Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 28:14:1282078.
doi: 10.3389/fimmu.2023.1282078. eCollection 2023.

Editorial: New insights of immune cells in cardiovascular and metabolic disorders

Yingmei Feng  1 , Xiangwei Xiao  2 , Catherine Verfaillie  3
Affiliations
Editorial

Editorial: New insights of immune cells in cardiovascular and metabolic disorders

Yingmei Feng et al. Front Immunol. .
No abstract available

Keywords: cardiovascular; diabetes; immune cells; insight; metabolic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic New insights of immune cells in cardiovascular and metabolic disorders

Similar articles

See all similar articles

References

    1. Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nat Rev Cardiol (2020) 17(7):387–401. doi: 10.1038/s41569-020-0352-5 - DOI - PMC - PubMed
    1. Pattarabanjird T, Li C, McNamara C. B cells in atherosclerosis: mechanisms and potential clinical applications. JACC Basic Transl Sci (2021) 6(6):546–63. doi: 10.1016/j.jacbts.2021.01.006 - DOI - PMC - PubMed
    1. Gao Z, Xu X, Li Y, Sun K, Yang M, Zhang Q, et al. Mechanistic insight into ppargamma and tregs in atherosclerotic immune inflammation. Front Pharmacol (2021) 12:750078. doi: 10.3389/fphar.2021.750078 - DOI - PMC - PubMed
    1. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med (2017) 377(12):1119–31. doi: 10.1056/NEJMoa1707914 - DOI - PubMed
    1. Zhao TX, Kostapanos M, Griffiths C, Arbon EL, Hubsch A, Kaloyirou F, et al. Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (Lilacs): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial. BMJ Open (2018) 8(9):e022452. doi: 10.1136/bmjopen-2018-022452 - DOI - PMC - PubMed

Publication types